# BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions

Study · id `cardio:ct-nct01426139` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01426139](<https://clinicaltrials.gov/study/NCT01426139>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01426139

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT01426139. Non-randomized; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2012-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT01426139, source copy `cardio:ctgov-nct01426139-2013-04-04`, retrieved 2026-10-26)
- Start date: 2011-08 (registry gives no type) (ClinicalTrials.gov record NCT01426139, source copy `cardio:ctgov-nct01426139-2013-04-04`, retrieved 2026-10-26)
- Primary completion: 2012-11 (actual) (ClinicalTrials.gov record NCT01426139, source copy `cardio:ctgov-nct01426139-2013-04-04`, retrieved 2026-10-26)
- Completion: 2013-02 (actual) (ClinicalTrials.gov record NCT01426139, source copy `cardio:ctgov-nct01426139-2013-04-04`, retrieved 2026-10-26)
- Countries: India (ClinicalTrials.gov record NCT01426139, source copy `cardio:ctgov-nct01426139-2013-04-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01426139-2013-04-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
- Condition: Coronary Artery Disease
- Intervention (Device): Percutaneous Coronary Intervention Biotronik Orsiro DES
- Lead sponsor: Biotronik AG
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Biotronik AG (`cardio:org-biotronik-ag`)

## Provenance

Content hash: b51a55ca040d4b0675307208fed165b0736c0a6656b5bb2fe40aed5a62a9ecde
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
